Back to news

Major Memphis Health System Expands BVA® Adoption to New Hospital Outpatient Site

Globe Newswire•18/11/2026•08:00 ET
0

Key Highlights

  • ➤Memphis health system expands Daxor BVA program to an additional hospital campus
  • ➤ezBVA Lab provides outpatient blood volume results within 24 hours
  • ➤Expansion uses established reimbursement codes and avoids capital budgets
  • ➤Daxor says centralized workflow supports rapid, cost-effective multi-site rollout

Expert Statements

Annette Plishka, SVP of Commercialization at Daxor

“Replicating adoption across multiple facilities within the same health system is a core driver of our commercial expansion.”

Annette Plishka, SVP of Commercialization at Daxor

“Because ezBVA Lab centralizes the analytical workflow in Tennessee, hospitals can bring new outpatient clinic locations online rapidly and cost-effectively.”

Annette Plishka, SVP of Commercialization at Daxor

“That operational simplicity accelerates our multi-site rollout, scales recurring diagnostic revenue, and equips care teams to manage patients before an acute hospitalization occurs.”

Daxor’s ezBVA Lab Diagnostic Service Delivers 24-hour Turnaround Under Established Reimbursement Pathways to Support Ambulatory Care

Oak Ridge, TN, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital campus, utilizing Daxor’s ezBVA Lab service to support outpatient clinic testing.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in